Comparison of once a day rifaximin to twice a day dosage in the prevention of recurrence of hepatic encephalopathy in patients with chronic liver disease

Publisher： John Wiley & Sons Inc

E-ISSN： 1440-1746|30|9|1420-1422

ISSN： 0815-9319

Source： JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, Vol.30, Iss.9, 2015-09, pp. : 1420-1422

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Myth: Interpretation of a single ammonia level in patients with chronic liver disease can confirm or rule out hepatic encephalopathy

By  

Canadian Journal of Emergency Medicine, Vol. 8, Iss. 6, 2006-11 ,pp. : 433-435

Cambridge University Press

Access to resources Recommend Favorite

Chronic Liver Disease Questionnaire would be a primary screening tool of neuropsychiatric test detecting minimal hepatic encephalopathy of cirrhotic patients

By  

HEPATOLOGY RESEARCH, Vol. 45, Iss. 9, 2015-09 ,pp. : 994-1003

John Wiley & Sons Inc

Access to resources Recommend Favorite

A modified (once a day) corticosteroid dosage regimen

By  

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 9-9236, Iss. 6part1, 1964-11 ,pp. : 721-727

John Wiley & Sons Inc

Access to resources Recommend Favorite

Chronic liver disease and 90‐day mortality in 21 359 patients following peptic ulcer bleeding – a Nationwide Cohort Study

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 41, Iss. 6, 2015-03 ,pp. : 564-572

John Wiley & Sons Inc

Access to resources Recommend Favorite

Comparative efficacy of once daily, 5-day short-course therapy with clarithromycin extended-release versus twice daily, 7-day therapy with clarithromycin immediate-release in acute bacterial exacerbation of chronic bronchitis

By Gotfried Mark   Notario Gerard   Spiller Joy   Palmer Robert   Busman Todd  

Current Medical Research and Opinion, Vol. 21, Iss. 2, 2005-02 ,pp. : 245-254

Informa Healthcare

Access to resources Recommend Favorite